Form 4: Standard BioTools CEO Sells Shares to Cover Tax Obligations

Standard BioTools CEO, Michael Egholm, sold 28,795 shares to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Michael Egholm, the President and CEO of Standard BioTools Inc., sold 28,795 shares of common stock on November 20, 2024.
• The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units granted on May 20, 2024.
• The shares were sold at a price of $1.51 per share.
• Following the transaction, Egholm directly owns 1,473,704 shares of Standard BioTools Inc.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across various industries.
• Similar transactions are frequently reported by executives in other biotechnology and life sciences companies.
• The number of shares sold and the price are specific to the individual's compensation package and the company's stock performance.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not indicate any change in the CEO's confidence in the company.

Key Dates

Keywords

Standard BioTools, Michael Egholm, stock sale, insider trading, tax obligations, restricted stock units, SEC Form 4